Intrinsic Value of S&P & Nasdaq Contact Us

Nexalin Technology, Inc. NXL NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
51/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nexalin Technology, Inc. (NXL) has a negative trailing P/E of -0.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -125.11%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -125.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 51/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NXL

Valuation Multiples
P/E (TTM)-0.8
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.75
P/S Ratio24.08
EV/EBITDA-0.8
Per Share Data
EPS (TTM)$-0.44
Book Value / Share$0.20
Revenue / Share$0.02
FCF / Share$-0.27
Yields & Fair Value
Earnings Yield-125.11%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -3.3 0.00 -13.89 78.98 -
2020 -4.8 0.15 -10.30 67.43 -
2021 -2.7 -0.04 -9.74 113.70 -
2022 -3.2 0.04 1.00 4.13 -
2023 -0.6 0.00 0.93 26.89 -
2024 -3.3 -0.11 6.92 150.75 -
2025 -1.1 0.03 2.44 30.32 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.69 $207.38K $-5.02M -2421.2%
2020 $-0.48 $242.91K $-3.48M -1433.5%
2021 $-0.85 $144.07K $-6.16M -4276.1%
2022 $-0.26 $1.32M $-1.93M -145.7%
2023 $-0.63 $110.75K $-4.65M -4197.6%
2024 $-0.83 $168.72K $-7.61M -4508.7%
2025 $-0.50 $301.65K $-8.22M -2725.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.39 $-0.39 – $-0.39 $660K $660K – $660K 1
2027 $-0.31 $-0.31 – $-0.31 $690K $690K – $690K 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message